We are excited to share that our member, IDEVAX, has released a white paper focusing on new delivery methods in the fight against vaccine-preventable diseases. This comprehensive paper delves into the potential of the skin as an optimal site for drug delivery and vaccination.
Key highlights include:
- Current challenges faced by large-scale vaccination campaigns
- The promise of skin vaccination as a dose-sparing alternative
- IDEVAX’s VAX-ID® solution, a novel skin drug delivery device
For a detailed exploration of these innovative approaches and solutions, read the full white paper here.